Study to Evaluate the Immunogenicity and Safety of Hantavax in Healthy Adult
NCT02553837
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
317
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
BIOLOGICAL:
Hantavax injection
Sponsor
Green Cross Corporation